Action - SCR

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

9,60

Prix Achat

Prix Vente

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

9,60

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders' equity, and proposes a dividend of ...

2014 Annual Results SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders' equity, and proposes a dividend of EUR 1.40, up 8% ...

SCOR Global Life supports Sun Life in the first longevity insurance transaction in Canada

PARIS, March 3, 2015 (GLOBE NEWSWIRE) -- Press Release 3 March 2015 - N°04 SCOR Global Life supports Sun Life in the first longevity insurance transaction in Canada...

January 2015 Renewals: SCOR Global P&C delivers premium growth of 2.4%, while maintaining expected profitability

PARIS, Feb. 10, 2015 (GLOBE NEWSWIRE) -- Contacts Marie-Laurence Bouchon Group Head of Communications +33 (0)1 58 44 76 10 mbouchon@scor.com Bertrand Bougon Head of Investor...

SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013

Paris, France, July 31, 2014 (GLOBE NEWSWIRE) -- Press Release ...

SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%

PARIS, May 6, 2014 (GLOBE NEWSWIRE) -- Press Release ...

SCOR posts record net income of EUR 549 million and an ROE of 11.5% in 2013, and proposes a dividend of EUR 1.30 per share[1]...

PARIS, March 5, 2014 (GLOBE NEWSWIRE) -- For more information, please contact: Géraldine Fontaine ...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SCR - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 9,60

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MBIMBIA Inc	US$ 7,11 (15,42%)	2,37M
ALURAllurion Technologies Inc	US$ 6,07 (13,46%)	571,74k
SESSES AI Corporation	US$ 1,19 (13,33%)	24,78M
ENFYEnlightify Inc	US$ 1,36 (12,40%)	95,69k
LITBLightInTheBox Holding Co Ltd	US$ 1,155 (12,14%)	17,51k
DECKDeckers Outdoor	US$ 177,46 (-20,46%)	15,04M
BZHBeazer Homes USA Inc New	US$ 22,18 (-19,93%)	2,11M
VSTSVestis Corporation	US$ 14,00 (-11,62%)	6,16M
KOREKORE Group Holdings Inc	US$ 2,29 (-9,13%)	36,39k
NOVASunnova Energy International Inc	US$ 2,565 (-9,04%)	14,63M
FFord Motor Company	US$ 10,08 (-0,79%)	103,99M
QBTSD Wave Quantum Inc	US$ 5,94 (5,32%)	75,07M
BBDBanco Bradesco SA	US$ 2,12 (0,47%)	55,89M
NUNu Holdings Ltd	US$ 13,25 (-1,41%)	48,21M
VZVerizon Communications Inc	US$ 39,39 (-0,20%)	45,19M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares (SCR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

SCR Dernières nouvelles

SCOR publishes a net income of EUR 512 million along with a 15% increase in shareholders' equity, and proposes a dividend of ...

SCOR Global Life supports Sun Life in the first longevity insurance transaction in Canada

January 2015 Renewals: SCOR Global P&C delivers premium growth of 2.4%, while maintaining expected profitability

SCOR delivers a strong performance for the first half 2014 with net income of EUR 256 million, up 35% from H1 2013

SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%

SCOR posts record net income of EUR 549 million and an ROE of 11.5% in 2013, and proposes a dividend of EUR 1.30 per share[1]...

SCOR Global P&C delivers strong January renewals with 5% premium growth and stable expected net technical profitability

Simcere Pharmaceutical Group Announces Completion of Merger

Simcere Pharmaceutical Group Announces Shareholders' Approval of the Merger Agreement

Simcere Pharmaceutical Group Provides Notice of Annual General Meeting

SCR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares (SCR) Cours

Simcere Pharmaceutical Grp. Simcere Pharmaceutical Grp. American Depositary Shares (SCR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

SCR Dernières nouvelles

SCR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE